These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16511430)

  • 41. Abacavir and lamivudine combination.
    Somboonwit C; Kurtyka D; Velez AP
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1599-606. PubMed ID: 19929448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abacavir-induced agranulocytosis in two Taiwanese patients tested HLA-B*5701-negative.
    Chen SJ; Yang SP; Hung CC; Fung CP
    AIDS; 2010 May; 24(8):1238-9. PubMed ID: 20421748
    [No Abstract]   [Full Text] [Related]  

  • 43. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction.
    AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of drug hypersensitivity in HIV-infected patients: the role of the immune system.
    Vilar FJ; Naisbitt DJ; Park BK; Pirmohamed M
    J HIV Ther; 2003 May; 8(2):42-7. PubMed ID: 12838164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abacavir hypersensitivity reaction.
    AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699
    [No Abstract]   [Full Text] [Related]  

  • 46. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
    King D; Tomkins S; Waters A; Easterbrook PJ; Thurmond LM; Thorborn DE; Raffi F; Kemeny DM; Vyakarnam A
    J Allergy Clin Immunol; 2005 May; 115(5):1081-7. PubMed ID: 15867870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir.
    Saumoy M; Ordoñez-Llanos J; Martínez E; Barragán P; Ribera E; Bonet R; Knobel H; Negredo E; Loncá M; Curran A; Gatell JM; Podzamczer D;
    Antivir Ther; 2011; 16(4):459-68. PubMed ID: 21685533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity.
    Frissen PH; de Vries J; Weigel HM; Brinkman K
    AIDS; 2001 Jan; 15(2):289. PubMed ID: 11216946
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-HIV agents. Abacavir once or twice daily.
    TreatmentUpdate; 2005; 17(5):8. PubMed ID: 17219659
    [No Abstract]   [Full Text] [Related]  

  • 50. Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative.
    Calza L; Rosseti N; Biagetti C; Pocaterra D; Colangeli V; Manfredi R
    Int J STD AIDS; 2009 Apr; 20(4):276-7. PubMed ID: 19304978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abacavir sulfate and mania in HIV.
    Brouilette MJ; Routy JP
    Am J Psychiatry; 2007 Jun; 164(6):979-80. PubMed ID: 17541065
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful implementation of a national HLA-B*5701 genetic testing service in Canada.
    Lalonde RG; Thomas R; Rachlis A; Gill MJ; Roger M; Angel JB; Smith G; Higgins N; Trottier B
    Tissue Antigens; 2010 Jan; 75(1):12-8. PubMed ID: 19843279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction.
    Escaut L; Liotier JY; Albengres E; Cheminot N; Vittecoq D
    AIDS; 1999 Jul; 13(11):1419-20. PubMed ID: 10449301
    [No Abstract]   [Full Text] [Related]  

  • 54. Anti-HIV agents. Who gets abacavir allergies?
    TreatmentUpdate; 2003 Oct; 15(6):4-5. PubMed ID: 17219615
    [No Abstract]   [Full Text] [Related]  

  • 55. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
    Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S
    Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
    Leeansyah E; Cameron PU; Solomon A; Tennakoon S; Velayudham P; Gouillou M; Spelman T; Hearps A; Fairley C; Smit de V; Pierce AB; Armishaw J; Crowe SM; Cooper DA; Koelsch KK; Liu JP; Chuah J; Lewin SR
    J Infect Dis; 2013 Apr; 207(7):1157-65. PubMed ID: 23303810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
    Keiser P; Nassar N; Skiest D; Andrews C; Yazdani B; White A; Hetherington S
    Int J STD AIDS; 2003 Jul; 14(7):478-81. PubMed ID: 12869229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding drug hypersensitivity: what to look for when prescribing abacavir.
    Hetherington S
    AIDS Read; 2001 Dec; 11(12):620-2. PubMed ID: 11806176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New variations in highly active antiretroviral therapy. Simple combination as a promising option].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():50-2. PubMed ID: 10863312
    [No Abstract]   [Full Text] [Related]  

  • 60. Disseminated intravascular coagulation as a manifestation of abacavir hypersensitivity reaction.
    Dargère S; Verdon R; Bouhier K; Bazin C
    AIDS; 2002 Aug; 16(12):1696-7. PubMed ID: 12172098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.